<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/EAA6A1E7-D911-4B65-858C-A7BA596672CB"><gtr:id>EAA6A1E7-D911-4B65-858C-A7BA596672CB</gtr:id><gtr:name>Saint Mary's Hospital, Manchester</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A19A6372-A1A2-4F0D-AED7-7110E0A05C9B"><gtr:id>A19A6372-A1A2-4F0D-AED7-7110E0A05C9B</gtr:id><gtr:name>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Midwifery and Women's Health</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EAA6A1E7-D911-4B65-858C-A7BA596672CB"><gtr:id>EAA6A1E7-D911-4B65-858C-A7BA596672CB</gtr:id><gtr:name>Saint Mary's Hospital, Manchester</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A19A6372-A1A2-4F0D-AED7-7110E0A05C9B"><gtr:id>A19A6372-A1A2-4F0D-AED7-7110E0A05C9B</gtr:id><gtr:name>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/49E7A3A0-05EB-419E-ADE6-CE97355D2F28"><gtr:id>49E7A3A0-05EB-419E-ADE6-CE97355D2F28</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:surname>Barratt</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/0B2EEBBF-6453-463B-823F-0E8322EE898F"><gtr:id>0B2EEBBF-6453-463B-823F-0E8322EE898F</gtr:id><gtr:firstName>Peter Riven</gtr:firstName><gtr:surname>Braude</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C1D23C0A-968A-4975-8260-9FC1A9585091"><gtr:id>C1D23C0A-968A-4975-8260-9FC1A9585091</gtr:id><gtr:firstName>Madhurima</gtr:firstName><gtr:surname>Rajkhowa</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/ED9FB392-1D46-44F1-A9B3-8C06A3F57446"><gtr:id>ED9FB392-1D46-44F1-A9B3-8C06A3F57446</gtr:id><gtr:firstName>Franchesca</gtr:firstName><gtr:surname>Houghton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A398B4B7-4241-4DF2-832E-097103A0A371"><gtr:id>A398B4B7-4241-4DF2-832E-097103A0A371</gtr:id><gtr:firstName>Lorraine</gtr:firstName><gtr:otherNames>Elizabeth</gtr:otherNames><gtr:surname>Young</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/013F6F3F-C8E9-4F3E-A98B-39487671AEA0"><gtr:id>013F6F3F-C8E9-4F3E-A98B-39487671AEA0</gtr:id><gtr:firstName>Siladitya</gtr:firstName><gtr:surname>Bhattacharya</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6C4735F4-44A5-49A7-A19B-3AFF802A1450"><gtr:id>6C4735F4-44A5-49A7-A19B-3AFF802A1450</gtr:id><gtr:firstName>Alison</gtr:firstName><gtr:surname>Murdoch</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B58C79FD-B156-44C1-BCB3-301E4927DC44"><gtr:id>B58C79FD-B156-44C1-BCB3-301E4927DC44</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Mardon</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/F785B423-CFB6-4A4C-B8BA-802DC65552DB"><gtr:id>F785B423-CFB6-4A4C-B8BA-802DC65552DB</gtr:id><gtr:firstName>Daniel</gtr:firstName><gtr:otherNames>R</gtr:otherNames><gtr:surname>Brison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700092"><gtr:id>C599616E-2A2A-4538-B0D9-4804F091AC5B</gtr:id><gtr:title>Recruiting donors for stem cell research -National collaboration of hESC coordinators</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700092</gtr:grantReference><gtr:abstractText>Human embryonic stem cells can be isolated from very early (6 days) developing embryos which have been grown in the laboratory as part of, or surplus to certain kinds of IVF treatment. Under certain conditions, these cells can be made to develop into different types of tissues, such as nerve or pancreas which it is hoped in the future, may be useful in treating degenerative diseases such as Parkinson s disease and diabetes, or in spinal injuries by replacing the diseased or damaged cells with healthy cells which have been grown in the laboratory. The number of embryonic stem cell lines that have been developed worldwide is still quite limited and further research is required to find out the best means to grow them in ways which will allow them to be safe for clinical use. In order to facilitate these developments, a National Stem Cell Bank has been established in the UK where stem cell lines can be deposited and stored, tested for safety, and then made available for research and clinical use. All stem cell derivation from embryos is strictly monitored in the UK and requires a licence from the Human Fertilisation and Embryology Authority. It is also a condition of licence that a sample of any suitable stem cell lines developed must sent to the UK Stem Cell Bank from where they are made available to research scientists in the UK and abroad
Deriving these embryonic stem cells ethically is critically dependent on identifying those patients who are prepared to donate to research any suitable embryos that are no longer needed for their IVF assisted conception treatment. In 2003 the MRC made funds available for the appointment of Nurse Coordinators, not involved directly in the stem cell derivation, who could counsel and advise patients that may be prepared to donate surplus embryos to stem cell programmes. They have been very successful and a number of lines have been submitted to the stem cell bank from this source. They have also established a UK network of stem cell coordinators (hESCCO) which facilitates their collaborative working and through which they have developed a national consent form for patients wishing to donate to stem cell research. The bid to the MRC is to continue funding of the nurse coordinators and their network.</gtr:abstractText><gtr:technicalSummary>The UK has been able to establish a pre-eminent position in stem cell derivation and research due the presence of highly regulated but permissive legislation, strong support from government, and strategic support for the funding councils. The remit of the UK Stem Cell Bank, is to provide quality assured banks of stem cell lines suitable for use in clinical trials according to the demands of the Human Tissues and Cells Directive and applicable medicines regulation. 
Ethical derivation of human embryonic stem cells is critically dependent on the availability of donated embryos obtained with transparent informed consent. Key to success is identifying patients prepared to donate embryos that are no longer needed for their assisted conception treatment using IVF, or from PGD centres that can generate lines containing specific clinically-relevant genetic defects. 
As a result of the MRC strategic call in 2003 to facilitate and support interactions between IVF clinicians and research teams, some centres appointed nurses to facilitate the recruitment of patients who would be prepared to donate to stem cell research, fresh or frozen embryos surplus to their treatment. Through their efforts a number of fully characterised stem cell lines have been submitted to the bank. Although not yet under GMP conditions suitable for clinical use, they are available internationally for research purposes through the MRC Stem Cell Steering Committee. 
Since the 2003 call, HFEA licence conditions now require a demonstrable separation between clinical and research decisions and information giving; hence the need for specific staff to fulfil this requirement if patient recruitment for stem cell generation is to continue.
One unique and positive outcome of the call has been the establishment of the UK Human Embryo Stem Cell Coordinators Network (hESCCO). With the support of the MRC, the coordinators have met biannually for a one-day meeting, which includes representatives of the MRC, HFEA and the UK stem cell bank. This collaborative working has enabled the development of a nationally agreed consent form for donation to stem cell generation, discussions over patient testing requirements with the regulators, sharing of information, recording of recruitment of patients to the various projects, and where appropriate, sharing of patients from different parts of the country who wish to donate. 
The aim of this application is to seek refunding of these coordinators to continue the facilitation of donors to stem cell derivation programmes, and to fund the biannual hESCCO meetings.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>239312</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Sheffield Teaching Hospitals NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Assisted Conception Unit</gtr:department><gtr:description>hESCCO (Human Embryonic Stem Cell Coordinators)</gtr:description><gtr:id>50A4C535-EB5D-4B26-8E57-80D3C4CDE93D</gtr:id><gtr:impact>A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.</gtr:impact><gtr:outcomeId>E304A1F9490-2</gtr:outcomeId><gtr:partnerContribution>Knowledge transfer and experience.Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saint Mary's Hospital, Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>hESCCO (Human Embryonic Stem Cell Coordinators)</gtr:description><gtr:id>5B31CF5E-4F2E-4C0D-9BAD-D29B95B9FD45</gtr:id><gtr:impact>A group patient information and consent form has been produced in the past to give patients uniform information. The group has established a website in which to communicate. We have also produced a joint publication - Ref 18154466.</gtr:impact><gtr:outcomeId>E304A1F9490-1</gtr:outcomeId><gtr:partnerContribution>Knowledge transfer and experience.Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>The hESCCO group was formed before this grant was approved. Therefore any collaborations made had already been established. With regard to this, we organised group meetings and established lines of communication between parties.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Saint Mary's Hospital, Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>hESCCO</gtr:description><gtr:id>47153F09-C5A2-4CDD-A748-2959363B0268</gtr:id><gtr:impact>Resulted in national consensus stem cell information leaflets and consent forms given to patients considering donating embryos for stem cell research. Please see G0700092 report for details of other outputs</gtr:impact><gtr:outcomeId>B7C0707914D-1</gtr:outcomeId><gtr:partnerContribution>Knowledge transfer and experience</gtr:partnerContribution><gtr:piContribution>Formation of a National network, human embryonic stem cell coordinators to facilitate collaboration of stem cell derivers, and their nurse coordinators.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio interview manchester</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>5194121F-1ED4-4911-892D-877D853764F3</gtr:id><gtr:impact>June 2009 Channel M Interview on Embryonic stem cells. BBC radio Manchester live interview on Embryonic stem cells

Improved public understanding of stem cells</gtr:impact><gtr:outcomeId>650F0F9595F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Westminster forum</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>9BCE316E-8BF0-4485-A163-675027FF4341</gtr:id><gtr:impact>Peter Braude and Alison Murdoch Oct 2007 The Future of regulation - Westminster Health Forum Seminar, Regulation with compassion

Invited parliamentarians and policy makers discussion and debate; document produced</gtr:impact><gtr:outcomeId>923A8F172A3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'Our Kid' Exhibition</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>FF19147B-C0A9-4DBD-92C2-F8DC16EBC9A8</gtr:id><gtr:impact>Exhibition celebrating the 60th anniversary of the birth of the NHS in Manchester. Recorded interview with Daniel Brison on embryonic stem cells, one of 6 chosen areas of scientific excellence at the University of Manchester. Available to general public throughout mid-2008.

improved understanding of relationship between fertility treatment and stem cell research</gtr:impact><gtr:outcomeId>930B583D4AD</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lancashire Humanists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B0931EE6-83B3-4D36-9819-7C568868A641</gtr:id><gtr:impact>70 people attenced a public lecture on stem cell biology

Requests for other talks to Humanist groups.</gtr:impact><gtr:outcomeId>YMajzoRVuaG</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Membership of HFEA's Scientific and Clinical Advances Advisory Committee</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>5C68A7BB-C797-4857-98DE-7A429ED2B1BF</gtr:id><gtr:impact>Membership of HFEA's Scientific and Clinical Advances Advisory Committee</gtr:impact><gtr:outcomeId>56ddec29aee746.47408668</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Grammar school presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E3C1BCC2-7F5C-45CA-844E-339115CC381E</gtr:id><gtr:impact>February 2009 Stem Cells. Invited presentation at Stockport Grammar School as part of the Junior Cafesci programme.

Improved understanding in schools about embryonic stem cell reserach</gtr:impact><gtr:outcomeId>F0BE5FC7E85</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Public Lecture Oxford</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>E3003B42-539A-4B5D-9446-6903A8F4618E</gtr:id><gtr:impact>May 2009 - Oxford May Music series- Human embryonic stem cells; Strings attached. General audience in science and music series.

Increased awareness of achievements of stem cell research and need for use of eggs and embryos</gtr:impact><gtr:outcomeId>1E69E57260F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Lecture to Tissue bankers</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>565BF0AE-D7DA-4D4C-B78C-AC7D6D240CAA</gtr:id><gtr:impact>Glenda Cornwell Apr 07 - &amp;quot;Embryonic stem cell donation: The hESCCO experience&amp;quot; British Association for Tissue Banking

Information to general tissue banking audience about recruiting donors to embryonic stem cell reserach Published abstract Abstracts from the Annual Scientific Meeting of the British Association for tissue banking</gtr:impact><gtr:outcomeId>40E8505F8BA</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Progress Educational Trust Meeting; ethics legal and social issues of stem cells</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>869AA3D9-36AC-49B1-9E1D-83BB2BF16744</gtr:id><gtr:impact>Key speaker in symposium for public and interested science groups - Putting stem cells into practice: ethical, legal and social issues.

Increased understanding or stem cell science and its relevance to science and health.</gtr:impact><gtr:outcomeId>EE7E12A7A9F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>British Embassy, Berlin</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>7025A484-AF10-475D-B1B6-AB6CCD8FDA64</gtr:id><gtr:impact>March 2009. Lecture on GMP human embryonic stem cells at DTI workshop.

HESCCO described and MRC support acknowledged, Summary reproduced in widely available handbook.</gtr:impact><gtr:outcomeId>53CAEB2858F</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Bioethics study day ~London</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>5E510C1A-E1CC-4FB0-9BDA-0F4F665A193F</gtr:id><gtr:impact>Glenda Cornwell &amp;amp; Emma Stephenson Churches Together in England Bioethics Discussion Day: Stem Cells - What are they and why might they be useful?

Advising and discussing with church ideas of stem cell research and need for use of human embryos</gtr:impact><gtr:outcomeId>40E8A66B21A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Joint meeting of French and US embassies, center for American Progress stem cell workshop</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>5F1073C9-57CC-47B5-9008-0D06A52C74FA</gtr:id><gtr:impact>Meeting to examine science and differences in policies in UK, USA and France

Contributed to review of legislation in France, NIH review of ES science, and UK legislation.</gtr:impact><gtr:outcomeId>113151A360B</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CMFT Xmas lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>58EFBEDF-FE23-4FA3-98AA-A556E374E863</gtr:id><gtr:impact>Xmas Royal Society-style lecture for Central Manchester NHS Foundation Trust &amp;quot;The Stem Cell Revolution&amp;quot;.

School visit requests</gtr:impact><gtr:outcomeId>54638c99079904.93253963</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Institute of Physics</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>57C4EE28-8E68-4C4E-924B-754B3E303561</gtr:id><gtr:impact>Oldershaw RA. (June 2009) Invited guest speaker at the Institute of Physics (IoP) Manchester teacher's conference &amp;quot;Stem Cells - Hype and Hope&amp;quot;.

This presentation was aimed to present an overview of the stem cell research being carried out at the University of Manchester in order that teachers can pass on to their students information about entering careers in science.</gtr:impact><gtr:outcomeId>6E448E5479A</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit of delegation from US senate and Congress</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>DC21B693-1E3D-47EC-8210-92C5D3A86693</gtr:id><gtr:impact>Participated in fact finding mission by supporters and sceptics of stem cell science from US to the UK.

Will have had an impact on voting in Stem cell issues in USA</gtr:impact><gtr:outcomeId>48424FBB0F2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview with Mark Porter</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A674FB59-AE28-4B33-A46E-2A316D4236B6</gtr:id><gtr:impact>Sue Kimber interviewed on Radio 4 Case Notes programme re stem cell therapies

Raised public awareness, led to doubled patient and GP interest in NWESCC</gtr:impact><gtr:outcomeId>BTUKp2y9J24</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Manchester Science and Literature Festival</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:id>BA1DEB91-6585-418E-932C-CB3FF21666AD</gtr:id><gtr:impact>Workshop for general public at Manchester Central Library on IVF and stem cells

improved public understanding of stem cell reserach</gtr:impact><gtr:outcomeId>F190721A889</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Radio 4 interview re 'Promising' stem cell trials for blindness</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>043AC525-3AEB-48C0-963D-2471946B7767</gtr:id><gtr:impact>Daniel Brison interviewed and commented on news story re stem cell therapies

Raising public awareness</gtr:impact><gtr:outcomeId>D64dC6mLWBJ</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>publication</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>C4820596-D702-4E19-9AC2-A5F042F5B5C5</gtr:id><gtr:impact>Publication from the hESCCO group

None</gtr:impact><gtr:outcomeId>81B4DD8C57C</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Embryologist national meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>21089C9A-DD2F-40F3-8E7E-0DC8146B6620</gtr:id><gtr:impact>Jan 09 - &amp;quot;Implications of donating embryos for stem cell research, ACE meeting, Edinburgh

Information for UK embryologists about stem cell research; need, and practical and ethical implications</gtr:impact><gtr:outcomeId>A727942E1A6</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecture to EU Student Parliament debate on embryo research</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7AAA0B4A-EE7A-433D-8990-C01B7F3DEA7A</gtr:id><gtr:impact>Invited lecture to EU Student parliament debate on human embryo research including embryonic stem cell derivation, in Salford, UK</gtr:impact><gtr:outcomeId>58c2cc3d81d642.34282301</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Undergraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>video clip on BBC website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7863E376-1075-42C9-BB6B-AF609C2630DA</gtr:id><gtr:impact>SERIES: Health Explained
TITLE: How to make stem cells
DATE OF PUBLICATION: 21 Jun 2012
URL: www.bbc.co.uk/news/health-18496355

promoting our research</gtr:impact><gtr:outcomeId>DQRMiZqboNv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>hESCCO website</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>8EC9B9F4-B871-4039-9C7D-5FED6B6919FB</gtr:id><gtr:impact>Set up a website for internal communication for coordinators and for use by patients for links and informatino etc.

None</gtr:impact><gtr:outcomeId>F49D25A04D2</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Membership of HFEA's Information for Quality Programme</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>4C6DCD51-8FC2-4B5D-BF7E-1CA8BE333D91</gtr:id><gtr:impact>Membership of HFEA's Information for Quality Programme</gtr:impact><gtr:outcomeId>56ddebc7db4261.70184186</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Guardian newspaper article on ART child health</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>DC4EC2CC-4897-4E05-9917-1B182DDE77B1</gtr:id><gtr:impact>Guardian newspaper article on ART child health</gtr:impact><gtr:outcomeId>56ddecf3cf1a48.66372587</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Parliamentary and Scientific Committee (Human Reproductive Technologies)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>F6A6D5AE-0421-4752-BA95-25312BDC823F</gtr:id><gtr:impact>Presentation to regular meeting of members or former members of Science and Technology Committee in House of Commons.

Influence thinking of key parliamentarians on Human Fertilisation and Embryology Bill revision</gtr:impact><gtr:outcomeId>355CBADCD91</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>New Scientist Article on ART child health</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>08A83C15-EF09-46AD-A6F8-0F4C6D48A50F</gtr:id><gtr:impact>Interview for article in New Scientist on research into ART child health</gtr:impact><gtr:outcomeId>56ddeb57a83b74.45824920</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Infertility nurses meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>DB6CEEFB-FFDE-486A-9972-6E35264A247D</gtr:id><gtr:impact>Glenda Cornwell Sept 07 - &amp;quot;Embryonic Stem Cell Research: The nurses role&amp;quot; National Fertility Nurse annual conference

Informing nurses involved in assisted conception units about need and use of surplus embryos for stem cell research</gtr:impact><gtr:outcomeId>25A3CD4B341</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Media Centre press conference</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6E6F8448-DDAD-401A-9672-2BF94B5153F9</gtr:id><gtr:impact>Press conference organised by SMC to discuss press release concerning submission of clinical grade embryonic stem cell lines to the UK Stem Cell Bank

Interest from media, followup stories. Followup contacts from industry resulting directly from press release.</gtr:impact><gtr:outcomeId>RS1hsH2BEqL</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>NIH hES consent revision</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:id>DAC154DD-F39C-4FEC-A9A4-C3F628A0A5F9</gtr:id><gtr:impact>hESCCO consent form submitted and used by NIH in their re-evaluation of hES availability.

Likelihood that hESCCO consent form used to demonstrate that NIH proposed criteria have been in place in UK successfully since 2007</gtr:impact><gtr:outcomeId>A507F567F37</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>270000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>NIHR Clinical fellowship</gtr:description><gtr:end>2021-05-02</gtr:end><gtr:fundingOrg>National Institutes of Health (NIH)</gtr:fundingOrg><gtr:id>93A2FAD6-B597-4650-A666-031B5C7B5EE6</gtr:id><gtr:outcomeId>56dde48f1c97f3.35792053</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1290000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC project grant</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017354/1</gtr:fundingRef><gtr:id>28EEBA9C-5186-4755-910C-1742329A4513</gtr:id><gtr:outcomeId>56dde5b09b9aa1.93333904</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME - EFREEZE</gtr:description><gtr:end>2018-07-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>4CAF74FF-D152-4FF4-B62A-35C17CDD037F</gtr:id><gtr:outcomeId>54636acfd39497.99464740</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>793000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Chondrocytes from clinical grade embryonic stem cells</gtr:description><gtr:end>2017-05-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L004992/1</gtr:fundingRef><gtr:id>25B900F3-112E-4773-A866-392765C8FDEE</gtr:id><gtr:outcomeId>54636c78631606.93067965</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>600000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (G0701172)</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>ECA41013-F237-4771-8636-268093AFD699</gtr:id><gtr:outcomeId>59B0706BC9F0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>110000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC icase studentship (with Argo)</gtr:description><gtr:end>2017-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>A15D63E4-DD03-4C8F-9A5F-944EA262ABC8</gtr:id><gtr:outcomeId>546369cf90f217.69073626</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>UK national ART cohort - Population and Systems Medicine Board</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L020335/1</gtr:fundingRef><gtr:id>16A07AE1-5405-47CE-8079-D3B6574F0557</gtr:id><gtr:outcomeId>546367d6a79c04.59498648</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EME - HaBSelect</gtr:description><gtr:end>2015-12-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>47584CE9-3586-4EA3-9C93-A6AF9830DC8F</gtr:id><gtr:outcomeId>54636a72020ab8.60854298</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Welcome biomedical ethics strategic award</gtr:description><gtr:end>2014-04-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>C040304C-99FE-4F90-AFA7-DFFC5D40128C</gtr:id><gtr:outcomeId>1645EBBF2A90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Toxicology programme</gtr:description><gtr:end>2018-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>B5D1872B-A35C-4864-A8F6-BD23726C8147</gtr:id><gtr:outcomeId>546369685a62f5.37018931</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>570000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Diabetes UK</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Diabetes UK</gtr:fundingOrg><gtr:id>795E29C9-2693-4F42-B3A0-0129A51AEFC3</gtr:id><gtr:outcomeId>56dde3c93b1d21.89024504</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>285607</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>Seventh Framework Programme (FP7)</gtr:department><gtr:description>EpiHealthNet</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>European Commission</gtr:fundingOrg><gtr:id>3C486B84-B3F4-4525-AEE5-7AB7F8784EBF</gtr:id><gtr:outcomeId>BUWjKm7HvNm</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Refurbishment of IVF lab and stem cell laboratories</gtr:description><gtr:end>2008-12-02</gtr:end><gtr:fundingOrg>King's College London</gtr:fundingOrg><gtr:id>C0C980A8-EA89-48A9-8316-EBB651DAD3DE</gtr:id><gtr:outcomeId>7599E6B11F30</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>484420</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Research Grant (G0801061)</gtr:description><gtr:end>2012-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7D855995-8101-443D-8960-974F6BEAFB0F</gtr:id><gtr:outcomeId>278CABF252D0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Advisory Committee on Safety of Cells Tissues and Organs</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9213B5FE-53AD-40E0-8705-FEAAA556564A</gtr:id><gtr:impact>Member advising on testing and use of reproductive and stem cell tissues.</gtr:impact><gtr:outcomeId>B2AC3159846</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>HFEA Information for Quality programme</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>EDC03704-9BBE-462C-9752-22EAEE0749E5</gtr:id><gtr:impact>acting as advisor to Human Fertilisation and Embryology Authority Information for quality programme which aims to improve regulatory oversight of the field including stem cell derivation, and improve information to patients and for delivery of clinical IVF services.</gtr:impact><gtr:outcomeId>5463b792049bb2.03091056</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influencing policy towards patenting of discoveries using hESC lines</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>8C54D5D7-CFFB-4CEC-B4DB-B5C0942D6B0D</gtr:id><gtr:outcomeId>rSU1QnSGJkR</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Clinical human Embryonic Stem Cell Forum</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2622D113-0C49-4B43-8231-C21012E039D7</gtr:id><gtr:impact>Standardisation of requirements for clinical grade embryonic stem cell lines. Prof Brison is vice-chair of this group</gtr:impact><gtr:outcomeId>JDzv2iuj9pu</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Japanese legal system</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AC427347-E316-4E48-9019-6D57356880E5</gtr:id><gtr:impact>Will influence next revision of Japanese legislation on assisted conception, donor recruitment, and interaction with scientists engaging in stem cell research</gtr:impact><gtr:outcomeId>661998BB737</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Stem Cells for Safer Medicine Panel Member</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>31E4DEBA-646D-421D-AD9E-641BAEA05D67</gtr:id><gtr:outcomeId>myxbn9Peruf</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Acad Med Sci report on interspecies hybrids</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>956F0008-9382-4B1A-9A6E-2F7A87864408</gtr:id><gtr:impact>Affected drafting of the revision Human Fertilisation and Embryology Act (2008)</gtr:impact><gtr:outcomeId>0DEC4A5C3E5</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>House of Commons Science and Technology Committee</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>4798AC9F-547A-435E-969F-4875B436F4B8</gtr:id><gtr:impact>Influenced demise of RATE and incorporation of stem cell and PGD clauses into HFE Act 2009. Changed policy on allowing embryos to be used for training as well as reserach</gtr:impact><gtr:outcomeId>CF7007ED796</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of HFEA's Scientific and Clinical Advances committee</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>81FA4DEB-043E-44BF-9EE8-391CAB3BEE20</gtr:id><gtr:impact>Advising the HFEA on changes in regulation on embryology and embryonic stem cell biology</gtr:impact><gtr:outcomeId>enWpVaz3Rgt</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of TERMIS Scientific Advisory Board</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>6BA76D13-8AF8-4E75-9D4B-A09B24501D21</gtr:id><gtr:outcomeId>magqDeYGPsY</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Setting standards for procurement of embryonic stem cells at clinical grade</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D19EE1AB-C2D4-4D35-AAF9-DE7F41BBA5EE</gtr:id><gtr:outcomeId>YykAiDHyyri</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Member of the HFEA Licensed Centres Panel</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>87CD82AF-6C13-4EB9-B042-88EA44896C3A</gtr:id><gtr:impact>The licensed Centres Panel informs on HFEA procedures and policy. Specifically the panel discusses how improvements can be made, their impact and how best to implement these changes eg the requirement for clinics to increase the number of single embryo transfers performed in clinical IVF. This will obviously reduce the number of multiple births, which is the greatest health risk for women undergoing fertility treatment</gtr:impact><gtr:outcomeId>SSAdQzngqhh</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Joint committee on the Human Tissue and Embryos (Draft) Bill</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>C00FEB05-A1AC-4D0F-92B8-2A9CB1620071</gtr:id><gtr:impact>Contributed to the demise of joint HFEA/HTA ALB to be called RATE. Remained as separate bodies and stem cell derivation remained under HFEA</gtr:impact><gtr:outcomeId>19D65C99E5D</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Route Map for Stem Cell Regulation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2D2DB493-E901-42A9-9BE4-791D313012F4</gtr:id><gtr:impact>Joint meeting of regulators to simplify processing of stem cell applications through HFEA, HTA, MHRA for clinical application</gtr:impact><gtr:outcomeId>71CD68B485D</gtr:outcomeId><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ESHRE working group on the impact of embryo culture medium on long term health</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>F8E0277B-740E-4E70-A218-04658D147784</gtr:id><gtr:outcomeId>56def2c72e6bf9.57948647</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Revision of Human Fertilisation and Embryology Act</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>73B5133B-2315-4C99-B5B7-0224A908F46A</gtr:id><gtr:impact>Inclusion of stem cell science and use of human embryos as part of research practice in UK</gtr:impact><gtr:outcomeId>hbK7c6hh5A9</gtr:outcomeId><gtr:type>Gave evidence to a government review</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>European human embryonic stem cell registry - hESCreg</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>8DF69185-CCAA-44F1-89DC-DA6BBF792344</gtr:id><gtr:impact>Provides information about what lines are available for distribution in Europe, their quality stage and particular characteristics which may be useful in developing lines for therapy</gtr:impact><gtr:outcomeId>94F370337B7</gtr:outcomeId><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cochrane guideline on embryo culture temperature</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>2CCAFA93-6F32-494E-826B-265D1932E5A6</gtr:id><gtr:outcomeId>56def31820d975.88069617</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>protocol for deriving chondrocyte progenitor cells for cartilage repair. Next stage of work funded by MRC to translate protocol to clinical grade with pre-clinical animal testing</gtr:description><gtr:id>0726A92F-C822-4236-ABBB-11AF802842D8</gtr:id><gtr:impact>impacts potential not yet realised</gtr:impact><gtr:outcomeId>M4QCkbx73S7</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Protocol for genererating chondrocyte pro-genitor cells from embryonic stem cells</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>A novel method of derivation of human embryonic stem cell lines.</gtr:description><gtr:id>452DCBA8-EEC4-4618-A18C-600EF8A08AD6</gtr:id><gtr:impact>Increased success rate at deriving stem cell lines.</gtr:impact><gtr:outcomeId>sEvaKoa5Lmv</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>A novel method of derivation of human embryonic stem cell lines</gtr:title><gtr:type>Support Tool - For Fundamental Research</gtr:type><gtr:yearDevCompleted>2011</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have derived 8 clincal grade hES cell lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133).</gtr:description><gtr:id>35EF277B-180B-4965-906C-DF7A222D5748</gtr:id><gtr:impact>We are in process of depositing lines in UKSCB. When process is completed, the lines will be available to researchers worldwide.</gtr:impact><gtr:outcomeId>ZCLCQMrrSgH</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Clinical grade hES cell lines</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have so far derived 22 lines carrying clinically relevant genetic mutations derived from affected embryos following preimplantation genetic diagnosis (PGD) (HFEA licence R0075) which includes cystic fibrosis (4 lines), Huntington's disease (7 lines), myotonic dystrophy type 1 (1 line), neurofibromatosis type 1 (2 lines), spinal muscular atrophy type 1 (1 line), Von Hippel-Lindau cancer syndrome (3 lines), ?-thalassemia (2 line), Wiskott-Aldrich syndrome and cystic fibrosis carrer (1 line), and Turner syndrome (1 line).</gtr:description><gtr:id>66484585-6211-471B-A538-4D878A92B231</gtr:id><gtr:impact>The cells are or will be deposited in the UK Stem Cell Bank. The deposition process is ongoing. The cell lines will be then be available to other researchers. 
The cell lines are also sumnitted to NIH Registry</gtr:impact><gtr:outcomeId>652C4860224</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Human embryonic stem cell lines with clinically relevant mutations</gtr:title><gtr:type>Cell line</gtr:type><gtr:url>http://www.kcl.ac.uk/medicine/research/divisions/wh/groups/medicine/hescell.aspx</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have derived 9 lines from normal embryos cryopreserved in-house or from one of the ten collaborating IVF units (HFEA licence R0133).</gtr:description><gtr:id>4E8076DB-3A34-4D15-92D6-19BA59B2779F</gtr:id><gtr:impact>The cell lines are either submitted or in process of submission to UKSCB. They will be available to researchers worldwide.</gtr:impact><gtr:outcomeId>059FB19D67D</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Reseearch grade normal hES cel lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2007</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>12E92857-EA28-4634-B5AC-84D7A0628863</gtr:id><gtr:title>Human feeder cell line for derivation and culture of hESc/hiPSc.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d233ec7c88eeed0e8516efa547bc6e9"><gtr:id>6d233ec7c88eeed0e8516efa547bc6e9</gtr:id><gtr:otherNames>McKay TR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56d9cc533589f7.53039517</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>135CBAF5-3A99-4BEC-B056-3191A3E52186</gtr:id><gtr:title>The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0ae23803e6e96e9fac7081387c099d5"><gtr:id>f0ae23803e6e96e9fac7081387c099d5</gtr:id><gtr:otherNames>Murdoch A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>56d9cc54e47b64.23834938</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A668466-4CBB-4DBA-B910-81BED80EADE8</gtr:id><gtr:title>Naturally immortalised mouse embryonic fibroblast lines support human embryonic stem cell growth.</gtr:title><gtr:parentPublicationTitle>Cloning and stem cells</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ad8f07a1e0b5b86dc4f9bbfb7c459893"><gtr:id>ad8f07a1e0b5b86dc4f9bbfb7c459893</gtr:id><gtr:otherNames>Camarasa M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1536-2302</gtr:issn><gtr:outcomeId>pm_15264_14_19594387</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>175CFA11-F450-4566-B632-0B2CF42E4F31</gtr:id><gtr:title>ACE consensus meeting report: oocyte and embryo cryopreservation Sheffield 17.05.11.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f9e96ff3845365a47234edf4e05a8ff"><gtr:id>1f9e96ff3845365a47234edf4e05a8ff</gtr:id><gtr:otherNames>Brison D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc54b57991.70372026</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2203A047-5E47-4DF2-9663-2336B56AE7C3</gtr:id><gtr:title>The use of single embryo transfer to reduce the incidence of twins: Implications and questions for practice from the 'towardSET?' project.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc535a7d53.74213134</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>72751B25-5683-48A6-8924-B992873592AB</gtr:id><gtr:title>Comparison of gene expression in fresh and frozen-thawed human preimplantation embryos.</gtr:title><gtr:parentPublicationTitle>Reproduction (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38baf0b6e80f9ea2fe8e09a071e833f6"><gtr:id>38baf0b6e80f9ea2fe8e09a071e833f6</gtr:id><gtr:otherNames>Shaw L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1470-1626</gtr:issn><gtr:outcomeId>pm_15264_24_22996807</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DD9A813-DCAA-4903-BB99-3FA5F381AFC3</gtr:id><gtr:title>Sox2 is essential for formation of trophectoderm in the preimplantation embryo.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d4ee4d9bcbab079c3db06775036a85b7"><gtr:id>d4ee4d9bcbab079c3db06775036a85b7</gtr:id><gtr:otherNames>Keramari M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d9cd5d2b2ec5.48139927</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F44F9A26-9322-4D80-8593-8814FCC98091</gtr:id><gtr:title>hESCCO: development of good practice models for hES cell derivation.</gtr:title><gtr:parentPublicationTitle>Regenerative medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/315e076c7dd8b26eda1dda4831d1b534"><gtr:id>315e076c7dd8b26eda1dda4831d1b534</gtr:id><gtr:otherNames>Franklin SB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1746-0751</gtr:issn><gtr:outcomeId>FF50B484C02</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CD6DEDB1-1CC6-4190-B99C-70B1D2DDC91A</gtr:id><gtr:title>When and how should new technology be introduced into the IVF laboratory?</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17036ea8e84d55655caae17c174bef6a"><gtr:id>17036ea8e84d55655caae17c174bef6a</gtr:id><gtr:otherNames>Harper J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc55b64e91.50826940</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>46E00F25-C251-4DB9-A1E5-F1253AE0D42A</gtr:id><gtr:title>Clinically failed eggs as a source of normal human embryo stem cells.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba0b6035e4458fc14d9c61658be76e45"><gtr:id>ba0b6035e4458fc14d9c61658be76e45</gtr:id><gtr:otherNames>De Sousa PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>48BC2B57FF8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0596341-1A1E-447B-A18D-7904EF587905</gtr:id><gtr:title>Embryo morphology as a predictor of IVF success: an evaluation of the proposed UK ACE grading scheme for cleavage stage embryos.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/db12c120e91a7fdacb8eca718fe5e7fd"><gtr:id>db12c120e91a7fdacb8eca718fe5e7fd</gtr:id><gtr:otherNames>Stylianou C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc5310b6f8.23110781</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>163163CF-488F-410E-8E78-39370A6D16BC</gtr:id><gtr:title>Directed differentiation of human embryonic stem cells toward chondrocytes.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/467776764ace099b543fb001950b0983"><gtr:id>467776764ace099b543fb001950b0983</gtr:id><gtr:otherNames>Oldershaw RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>56d9cc53e8d673.25996197</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7BC952B3-A300-4173-A4BF-41D76DA39816</gtr:id><gtr:title>Factors affecting embryo viability and uterine receptivity: insights from an analysis of the UK registry data.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>56d9cc52adf7e5.49817140</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F55948F8-D276-447C-A139-03BDC7F63F17</gtr:id><gtr:title>The IVF-stem cell interface.</gtr:title><gtr:parentPublicationTitle>International journal of surgery (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a070665e915f249bbabdc3bd4c88892e"><gtr:id>a070665e915f249bbabdc3bd4c88892e</gtr:id><gtr:otherNames>Franklin S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1743-9159</gtr:issn><gtr:outcomeId>36897F68E0D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C68E8961-CA42-4B03-9E3E-95A2974AA7CD</gtr:id><gtr:title>Biological optimization, the Goldilocks principle, and how much is lagom in the preimplantation embryo.</gtr:title><gtr:parentPublicationTitle>Molecular reproduction and development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc86168aa0009a12492b860b6e9a88c1"><gtr:id>bc86168aa0009a12492b860b6e9a88c1</gtr:id><gtr:otherNames>Leese HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1040-452X</gtr:issn><gtr:outcomeId>58c2c27443da10.13072325</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C251CE3-9FF1-40F8-BCB4-5A41A86454EE</gtr:id><gtr:title>Comparative proteomic analysis of supportive and unsupportive extracellular matrix substrates for human embryonic stem cell maintenance.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d992313132f7fc5b483dddbe10900065"><gtr:id>d992313132f7fc5b483dddbe10900065</gtr:id><gtr:otherNames>Soteriou D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>pm_15264_24_23658023</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A92B384E-EAA5-432C-A0FF-07F4127AB8C8</gtr:id><gtr:title>Generating cartilage repair from pluripotent stem cells.</gtr:title><gtr:parentPublicationTitle>Tissue engineering. Part B, Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bc25f202f0a7e25ac3d6deaad2005b"><gtr:id>d8bc25f202f0a7e25ac3d6deaad2005b</gtr:id><gtr:otherNames>Cheng A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1937-3368</gtr:issn><gtr:outcomeId>pm_15264_24_23957872</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11DA541E-8378-4B33-9CEB-31CF88B681A4</gtr:id><gtr:title>No common denominator: a review of outcome measures in IVF RCTs.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f9605c5e32e31e25cde9b73007beb93"><gtr:id>9f9605c5e32e31e25cde9b73007beb93</gtr:id><gtr:otherNames>Wilkinson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>58c2c273e41bc1.06220520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C666F6D3-FB91-4A68-8F5F-D72BC44D53E3</gtr:id><gtr:title>How should we assess the safety of IVF technologies?</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>pm_15264_24_24145118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D67B5B9D-8A6B-4B3A-B39F-80803580C958</gtr:id><gtr:title>Challenges imposed by scientific development in ART.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>953AF71BF31</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>48206B54-0140-48AA-8ACA-101470E01542</gtr:id><gtr:title>Metabolic heterogeneity during preimplantation development: the missing link?</gtr:title><gtr:parentPublicationTitle>Human reproduction update</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4786</gtr:issn><gtr:outcomeId>546362cc152139.43556606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A927E7C3-09CD-4E8D-8D4D-8107080FFFF0</gtr:id><gtr:title>Gene expression analysis of a new source of human oocytes and embryos for research and human embryonic stem cell derivation.</gtr:title><gtr:parentPublicationTitle>Fertility and sterility</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4931d24d2dd4026a98cbdb093c07d493"><gtr:id>4931d24d2dd4026a98cbdb093c07d493</gtr:id><gtr:otherNames>Sneddon SF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0015-0282</gtr:issn><gtr:outcomeId>56d9cc53c528d5.91402441</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96A69231-2940-4C44-A1A9-DA88032AB364</gtr:id><gtr:title>The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/93977d2ba9fe935c99b3418690c14eaf"><gtr:id>93977d2ba9fe935c99b3418690c14eaf</gtr:id><gtr:otherNames>Canham MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d9cc52d88874.18293894</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1E7CEA3B-A510-4EB8-8B6E-81029A59F44B</gtr:id><gtr:title>Elective Single Embryo Transfer: an update to UK Best Practice Guidelines.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a14ab8d4d51dac3af2b2d3d0bb6f062"><gtr:id>2a14ab8d4d51dac3af2b2d3d0bb6f062</gtr:id><gtr:otherNames>Harbottle S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc543d9a09.74142785</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD8C0566-564E-49A5-B4E4-96FE407A319A</gtr:id><gtr:title>Global gene expression profiling of individual human oocytes and embryos demonstrates heterogeneity in early development.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/38baf0b6e80f9ea2fe8e09a071e833f6"><gtr:id>38baf0b6e80f9ea2fe8e09a071e833f6</gtr:id><gtr:otherNames>Shaw L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_15264_24_23717564</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FB3EA940-2F9D-43F3-8606-2EA05A77F616</gtr:id><gtr:title>Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.</gtr:title><gtr:parentPublicationTitle>Nature biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac8dda101d738f96423f3e6d8bd9cce1"><gtr:id>ac8dda101d738f96423f3e6d8bd9cce1</gtr:id><gtr:otherNames>International Stem Cell Initiative</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1087-0156</gtr:issn><gtr:outcomeId>jzFxKPfjCpZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE707230-79D5-4EED-A1C6-6081FB3847A9</gtr:id><gtr:title>Symposium: innovative techniques in human embryo viability assessment. Assessing embryo viability by measurement of amino acid turnover.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1b8b50cd4f342349ef928277625de405"><gtr:id>1b8b50cd4f342349ef928277625de405</gtr:id><gtr:otherNames>Sturmey RG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>56d9cc5594c3e4.92819350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2050197F-7393-4C9E-BEB0-C7D7D90F62E6</gtr:id><gtr:title>Reducing the incidence of twins from IVF treatments: predictive modelling from a retrospective cohort.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc539bbba2.14972101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C188E492-B377-474C-BF40-98E0CB5128DA</gtr:id><gtr:title>Testing for hypersensitivity to seminal fluid-free spermatozoa.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/748e4b4c02ccd873019dbeba2f0eb633"><gtr:id>748e4b4c02ccd873019dbeba2f0eb633</gtr:id><gtr:otherNames>Carroll M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>546362cbbd47c1.98998652</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E7365B1A-41C0-4833-941D-3C218FD9DB97</gtr:id><gtr:title>ACE consensus meeting report: culture systems.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/209bbf8a071fc6234a1542a2569ff08e"><gtr:id>209bbf8a071fc6234a1542a2569ff08e</gtr:id><gtr:otherNames>Bolton VN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>546362cc3f0169.93698456</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57F7DB83-1FF4-4CE8-861E-32D1429D5877</gtr:id><gtr:title>Metabolism of the viable mammalian embryo: quietness revisited.</gtr:title><gtr:parentPublicationTitle>Molecular human reproduction</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc86168aa0009a12492b860b6e9a88c1"><gtr:id>bc86168aa0009a12492b860b6e9a88c1</gtr:id><gtr:otherNames>Leese HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1360-9947</gtr:issn><gtr:outcomeId>56d9cc553a0441.80385422</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17A35EA8-AFB8-412A-BD9C-842E09D9AC54</gtr:id><gtr:title>Derivation of Man-1 and Man-2 research grade human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>In vitro cellular &amp; developmental biology. Animal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeddc0f73525a60b36da7bf0b7dbad5"><gtr:id>aeeddc0f73525a60b36da7bf0b7dbad5</gtr:id><gtr:otherNames>Camarasa MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1071-2690</gtr:issn><gtr:outcomeId>56d9cc548d4301.74035907</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85324640-0795-46F9-8BDD-7B79BE295622</gtr:id><gtr:title>Analysis of the distinct functions of growth factors and tissue culture substrates necessary for the long-term self-renewal of human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9ba1569cd98c74f7d57fc9f3abdeef5"><gtr:id>f9ba1569cd98c74f7d57fc9f3abdeef5</gtr:id><gtr:otherNames>Baxter MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1873-5061</gtr:issn><gtr:outcomeId>56d9cd5d64b735.19103166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E260B72-8ACA-4F16-B531-1AF34DFA269A</gtr:id><gtr:title>Time to take human embryo culture seriously.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ea5b5fbc9b3dced0d706343485c6bd9"><gtr:id>1ea5b5fbc9b3dced0d706343485c6bd9</gtr:id><gtr:otherNames>Sunde A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>58c2c2741c1f75.64881741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>179DCDC4-C0B3-4358-8258-B2C9B144AF56</gtr:id><gtr:title>MiR-145 suppresses embryo-epithelial juxtacrine communication at implantation by modulating maternal IGF1R.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/61b22fd142b550e7e1b873d06726a9af"><gtr:id>61b22fd142b550e7e1b873d06726a9af</gtr:id><gtr:otherNames>Kang YJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn><gtr:outcomeId>56d9cd5cdd5452.26011916</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5885E05C-25A1-4F61-960D-758CA2344013</gtr:id><gtr:title>Current evidence for ART practice: the Cochrane of Cochranes on optimising outcomes.</gtr:title><gtr:parentPublicationTitle>Evidence-based medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6745dc9d496018514a97679b9b676727"><gtr:id>6745dc9d496018514a97679b9b676727</gtr:id><gtr:otherNames>Harper JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1356-5524</gtr:issn><gtr:outcomeId>546362cbe187f4.95407788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77CAAD15-2C4B-4808-A8DC-D5F08AB485B1</gtr:id><gtr:title>Polymer Supported Directed Differentiation Reveals a Unique Gene Signature Predicting Stable Hepatocyte Performance.</gtr:title><gtr:parentPublicationTitle>Advanced healthcare materials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88faafb158d268b797c8d4d26509a188"><gtr:id>88faafb158d268b797c8d4d26509a188</gtr:id><gtr:otherNames>Villarin BL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2192-2640</gtr:issn><gtr:outcomeId>5675e7477f915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>656BBE30-021F-40DD-9C5E-B0FF5F4C7829</gtr:id><gtr:title>Prognostic factors influencing fresh and frozen IVF outcomes: an analysis of the UK national database.</gtr:title><gtr:parentPublicationTitle>Reproductive biomedicine online</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c51df207093de5199ab22532ef58862"><gtr:id>0c51df207093de5199ab22532ef58862</gtr:id><gtr:otherNames>Hirst WM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1472-6483</gtr:issn><gtr:outcomeId>56d9cc537bc6d6.23328587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83E5A227-DA60-4C70-BC18-3A26D06D35A2</gtr:id><gtr:title>Cartilage repair using human embryonic stem cell-derived chondroprogenitors.</gtr:title><gtr:parentPublicationTitle>Stem cells translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8bc25f202f0a7e25ac3d6deaad2005b"><gtr:id>d8bc25f202f0a7e25ac3d6deaad2005b</gtr:id><gtr:otherNames>Cheng A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2157-6564</gtr:issn><gtr:outcomeId>5463642c2e2f32.44160384</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>842B13DF-864F-4F32-9526-81C2212308D7</gtr:id><gtr:title>Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells.</gtr:title><gtr:parentPublicationTitle>Journal of the Royal Society, Interface</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e2c772848d7675ee6ce668c80fc6d9c"><gtr:id>3e2c772848d7675ee6ce668c80fc6d9c</gtr:id><gtr:otherNames>Stephenson E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1742-5662</gtr:issn><gtr:outcomeId>dQswUNUA8VG</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AA7C2FF-C1C8-49C6-99E0-CE41BF7DBA3B</gtr:id><gtr:title>Modelling the impact of single embryo transfer in a national health service IVF programme.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc556d81f1.59601993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>669445CA-BC78-479A-953F-26C38B6058F1</gtr:id><gtr:title>Alkylation of sperm DNA is associated with male factor infertility and a reduction in the proportion of oocytes fertilised during assisted reproduction.</gtr:title><gtr:parentPublicationTitle>Mutation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c66517cfba3d0931b2c12ef8a4b9a38"><gtr:id>0c66517cfba3d0931b2c12ef8a4b9a38</gtr:id><gtr:otherNames>Stocks SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0027-5107</gtr:issn><gtr:outcomeId>56d9cc5467e832.15969435</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C98264BF-1C5C-4E56-B8B5-E9D14D0E2C54</gtr:id><gtr:title>Embryo and uterine influences on IVF outcomes: an analysis of a UK multi-centre cohort.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e9d5e9177843ea6bcf4fb1b7418b0653"><gtr:id>e9d5e9177843ea6bcf4fb1b7418b0653</gtr:id><gtr:otherNames>Roberts SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>56d9cc5418f3c6.08952205</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADB7F8ED-7C7E-4A2E-8668-0ECE1C5A5985</gtr:id><gtr:title>Controversies in clinical embryology: embryo selection towards single embryo transfer - 16 July 2008, University of Manchester.</gtr:title><gtr:parentPublicationTitle>Human fertility (Cambridge, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/35fd3108133ce098bcd90592e68f235a"><gtr:id>35fd3108133ce098bcd90592e68f235a</gtr:id><gtr:otherNames>Brison DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1464-7273</gtr:issn><gtr:outcomeId>56d9cc5516e351.46521964</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD8D0DB3-DA21-4EAE-A7D1-DBEA0901A122</gtr:id><gtr:title>Optimized protocol for derivation of human embryonic stem cell lines.</gtr:title><gtr:parentPublicationTitle>Stem cell reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aeeddc0f73525a60b36da7bf0b7dbad5"><gtr:id>aeeddc0f73525a60b36da7bf0b7dbad5</gtr:id><gtr:otherNames>Camarasa MV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1550-8943</gtr:issn><gtr:outcomeId>pm_15264_24_22614996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39454AF1-EF8E-4020-AFB5-BCA885D5D822</gtr:id><gtr:title>'Not taken in by media hype': how potential donors, recipients and members of the general public perceive stem cell research.</gtr:title><gtr:parentPublicationTitle>Human reproduction (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e7d60bb449f1fb09cba275e964ad4297"><gtr:id>e7d60bb449f1fb09cba275e964ad4297</gtr:id><gtr:otherNames>Peddie VL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0268-1161</gtr:issn><gtr:outcomeId>390F54837AD</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700092</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>34</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>A056411B-DD7A-4062-BE33-7849FBC9BFA7</gtr:id><gtr:percentage>33</gtr:percentage><gtr:text>5.9  Resources and infrastructure (development of treatments)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>